{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:08:25Z","timestamp":1790730505328,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12876-016-0535-z","type":"journal-article","created":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T23:48:01Z","timestamp":1475797681000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Faecal calprotectin: factors affecting levels and its potential role as a surrogate marker for risk of development of Crohn\u2019s Disease"],"prefix":"10.1186","volume":"16","author":[{"given":"Michael A.","family":"Mendall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshani","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devinder","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,7]]},"reference":[{"issue":"7351","key":"535_CR1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature10209","volume":"474","author":"B Khor","year":"2011","unstructured":"Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474(7351):307\u201317.","journal-title":"Nature"},{"key":"535_CR2","unstructured":"Vardulaki K, Langham J, Chandramohan D. Introduction to epidemiology. London: Open University Press; 2005 Ch7, p75."},{"issue":"145","key":"535_CR3","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1053\/j.gastro.2013.09.033","volume":"5","author":"GG Kaplan","year":"2013","unstructured":"Kaplan GG. Does consuming the recommend daily level of fiber prevent Crohn\u2019s disease? Gastroenterology. 2013;5(145):925\u20137.","journal-title":"Gastroenterology"},{"key":"535_CR4","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1002\/ibd.20575","volume":"14","author":"CL Noble","year":"2008","unstructured":"Noble CL, Arnott IDR. What is the risk that a child will develop inflammatory bowel disease if 1 or both parents have IBD? Inflamm Bowel Dis. 2008;14:S22\u20133.","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"535_CR5","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0016-5085(03)00383-4","volume":"124","author":"B Thjodleifsson","year":"2003","unstructured":"Thjodleifsson B, et al. Subclinical intestinal inflammation: an inherited abnormality in Crohn\u2019s disease relatives? Gastroenterology. 2003;124(7):1728\u201337.","journal-title":"Gastroenterology"},{"key":"535_CR6","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1046\/j.1365-2036.2001.00981.x","volume":"15","author":"T Ahmad","year":"2001","unstructured":"Ahmad T, Satsangi J, McGovern D, Bunce M, Jewell DP. The genetics of inflammatory bowel disease. Aliment Pharmacol Ther. 2001;15:731\u201348.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"535_CR7","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1053\/j.gastro.2015.01.026","volume":"148","author":"EK Wright","year":"2015","unstructured":"Wright EK, et al. Measurement of Fecal Calprotectin Improves Monitoring and Detection of Recurrence of Crohn\u2019s Disease After Surgery. Gastroenterology. 2015;148(5):938\u201347.","journal-title":"Gastroenterology"},{"issue":"4","key":"535_CR8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrgastro.2015.34","volume":"12","author":"AN Ananthakrishnan","year":"2015","unstructured":"Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12(4):205\u201317.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"535_CR9","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/gut.47.4.506","volume":"47","author":"J Tibble","year":"2000","unstructured":"Tibble J, Teahon K, Thjodleifsson B, et al. A simple method for assessing intestinal inflammation in Crohn\u2019s disease. Gut. 2000;47(4):506\u201313.","journal-title":"Gut"},{"issue":"9","key":"535_CR10","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S1590-8658(03)00381-5","volume":"35","author":"F Costa","year":"2003","unstructured":"Costa F, Mumolo MG, Bellini M, et al. Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Dig Liver Dis. 2003;35(9):642\u20137.","journal-title":"Dig Liver Dis"},{"issue":"10","key":"535_CR11","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1080\/00365520410007971","volume":"39","author":"AG R\u00f8seth","year":"2004","unstructured":"R\u00f8seth AG, Aadland E, Grzyb K. Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease. Scand J Gastroenterol. 2004;39(10):1017.","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"535_CR12","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/gut.2005.069476","volume":"55","author":"S Vermeire","year":"2006","unstructured":"Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut. 2006;55(3):426\u201331.","journal-title":"Gut"},{"key":"535_CR13","doi-asserted-by":"crossref","first-page":"c3369","DOI":"10.1136\/bmj.c3369","volume":"341","author":"PF Rheenen Van","year":"2010","unstructured":"Van Rheenen PF, Van de Vijver E, Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ. 2010;341:c3369.","journal-title":"BMJ"},{"issue":"10","key":"535_CR14","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/ibd.22861","volume":"18","author":"R Mao","year":"2012","unstructured":"Mao R, Gao X, et al. Fecal calprotectin in predicting relapse of inflammatory bowel diseases: A meta-analysis of prospective studies. Inflamm Bowel Dis. 2012;18(10):1894\u20139.","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"535_CR15","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1053\/j.gastro.2010.11.058","volume":"140","author":"JD Lewis","year":"2011","unstructured":"Lewis JD. The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology. 2011;140(6):1817\u201326.","journal-title":"Gastroenterology"},{"issue":"1","key":"535_CR16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/gast.2000.8523","volume":"119","author":"JA Tibble","year":"2000","unstructured":"Tibble JA, Sigthorsson G, Bridger S, et al. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology. 2000;119(1):15\u201322.","journal-title":"Gastroenterology"},{"issue":"2","key":"535_CR17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.crohns.2009.09.008","volume":"4","author":"V Garc\u00eda-S\u00e1nchez","year":"2010","unstructured":"Garc\u00eda-S\u00e1nchez V, Iglesias-Flores E, Gonzalez R, et al. Does fecal calprotectin predict relapse in patients with Crohn\u2019s disease and ulcerative colitis? J Crohns Colitis. 2010;4(2):144\u201352.","journal-title":"J Crohns Colitis"},{"issue":"6","key":"535_CR18","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/00054725-200606000-00013","volume":"12","author":"MR Konikoff","year":"2006","unstructured":"Konikoff MR, Denson LA. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm Bowel Dis. 2006;12(6):524\u201334.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"535_CR19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1158\/1055-9965.EPI-03-0160","volume":"13","author":"A Poullis","year":"2004","unstructured":"Poullis A, Foster R, Shetty A, et al. Bowel inflammation as measured by fecal calprotectin a link between lifestyle factors and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2004;13(2):279\u201384.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"535_CR20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00042737-200305000-00021","volume":"15","author":"A Poullis","year":"2003","unstructured":"Poullis A, Foster R, Mendall MA. Proton pump inhibitors are associated with elevation of faecal calprotectin and may affect specificity. Eur J Gastroenterol Hepatol. 2003;15(5):573\u20134.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"11\u201312","key":"535_CR21","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/j.1365-2036.2010.04475.x","volume":"32","author":"J Brignardello","year":"2010","unstructured":"Brignardello J, Morales P, Diaz E, et al. Pilot study: alterations of intestinal microbiota in obese humans are not associated with colonic inflammation or disturbances of barrier function. Aliment Pharmacol Ther. 2010;32(11\u201312):1307\u201314.","journal-title":"Aliment Pharmacol Ther"},{"key":"535_CR22","volume-title":"Relationship between severe obesity and gut inflammation in children: whatLs next?","author":"MI Spagnuolo","year":"2010","unstructured":"Spagnuolo MI, Cicalese MP, Caiazzo MA, et al. Relationship between severe obesity and gut inflammation in children: whatLs next? 2010."},{"issue":"2","key":"535_CR23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ijo.2012.38","volume":"37","author":"P Kant","year":"2013","unstructured":"Kant P, Fazarkerley R, Hull MA. Faecal calprotectin levels before and after weight loss in obese and overweight subjects. Int J Obes (Lond). 2013;37(2):317\u20139.","journal-title":"Int J Obes (Lond)"},{"issue":"12","key":"535_CR24","doi-asserted-by":"crossref","first-page":"E607","DOI":"10.1002\/oby.20466","volume":"21","author":"FJ Verdam","year":"2013","unstructured":"Verdam FJ, Fuentes S, de Jonge C, et al. Human intestinal microbiota composition is associated with local and systemic inflammation in obesity. Obesity. 2013;21(12):E607\u201315.","journal-title":"Obesity"},{"issue":"4","key":"535_CR25","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/ajcn\/83.4.760","volume":"83","author":"Y Ma","year":"2006","unstructured":"Ma Y, Griffith JA, Chanson-Taber L, et al. Association between dietary fiber and serum C-reactive protein. Am J Clin Nutr. 2006;83(4):760\u20136.","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"535_CR26","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/mnfr.201100630","volume":"56","author":"L Gentschew","year":"2012","unstructured":"Gentschew L, Ferguson LR. Role of nutrition and microbiota in susceptibility to inflammatory bowel diseases. Mol Nutr Food Res. 2012;56(4):524\u201335.","journal-title":"Mol Nutr Food Res"},{"key":"535_CR27","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","volume":"29","author":"MF Gregor","year":"2011","unstructured":"Gregor MF, Hotamisligrl GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29:415\u201345.","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"535_CR28","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1053\/j.gastro.2009.01.075","volume":"136","author":"SM Collins","year":"2009","unstructured":"Collins SM, Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology. 2009;136(6):2003\u201314.","journal-title":"Gastroenterology"},{"issue":"12","key":"535_CR29","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1136\/gutjnl-2013-306541","volume":"63","author":"SF Clarke","year":"2014","unstructured":"Clarke SF, Murphy EF, O\u2019Sullivan O, et al. Exercise and associated dietary extremes impact on gut microbial diversity. Gut. 2014;63(12):1913\u201320. gutjnl-2013.","journal-title":"Gut"},{"issue":"12","key":"535_CR30","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1136\/gutjnl-2014-307305","volume":"63","author":"G Hold","year":"2014","unstructured":"Hold G. The gut microbiota, dietary extremes and exercise. Gut. 2014;63(12):1838\u20139.","journal-title":"Gut"},{"issue":"5","key":"535_CR31","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.clnu.2012.02.009","volume":"31","author":"TFS Teixeira","year":"2012","unstructured":"Teixeira TFS, et al. Intestinal permeability parameters in obese patients are correlated with metabolic syndrome risk factors. Clin Nutr. 2012;31(5):735\u201340.","journal-title":"Clin Nutr"},{"issue":"6","key":"535_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11894-013-0326-4","volume":"15","author":"A Aujnarain","year":"2013","unstructured":"Aujnarain A, Mack DR, Benchimol EI. The role of the environment in the development of pediatric inflammatory bowel disease. Curr Gastroenterol Rep. 2013;15(6):1\u201311.","journal-title":"Curr Gastroenterol Rep"},{"key":"535_CR33","doi-asserted-by":"crossref","unstructured":"Lakatos PL, Burisch J. Environment and invironment in IBDs: partners in crime. Gut. 2015;64:1009\u201310.","DOI":"10.1136\/gutjnl-2014-308460"},{"issue":"5","key":"535_CR34","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7326\/0003-4819-156-5-201203060-00007","volume":"156","author":"AN Ananthakrishnan","year":"2012","unstructured":"Ananthakrishnan AN, Higuchi LM, Huang ES, et al. Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study. Ann Intern Med. 2012;156(5):350\u20139.","journal-title":"Ann Intern Med"},{"issue":"5","key":"535_CR35","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1053\/j.gastro.2013.07.050","volume":"145","author":"AN Ananthakrishnan","year":"2013","unstructured":"Ananthakrishnan AN, Khalili H, Konijeti GG, et al. A prospective study of long-term intake of dietary fiber and risk of Crohn\u2019s disease and ulcerative colitis. Gastroenterology. 2013;145(5):970\u20137.","journal-title":"Gastroenterology"},{"issue":"5","key":"535_CR36","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/gutjnl-2013-305304","volume":"63","author":"AN Ananthakrishnan","year":"2014","unstructured":"Ananthakrishnan AN, Khalili H, Konijeti GG, et al. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn\u2019s disease. Gut. 2014;63(5):776\u201384.","journal-title":"Gut"},{"issue":"4","key":"535_CR37","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/ajg.2012.453","volume":"108","author":"SS Chan","year":"2013","unstructured":"Chan SS, Luben R, Olsen A, et al. Body mass index and the risk for Crohn\u2019s disease and ulcerative colitis: data from a European Prospective Cohort Study (The IBD in EPIC Study). Am J Gastroenterol. 2013;108(4):575\u201382.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"535_CR38","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2036.2011.04784.x","volume":"34","author":"SS Chan","year":"2011","unstructured":"Chan SS, Luben R, Bergmann MM, et al. Aspirin in the aetiology of Crohn\u2019s disease and ulcerative colitis: a European prospective cohort study. Aliment Pharmacol Ther. 2011;34(6):649\u201355.","journal-title":"Aliment Pharmacol Ther"},{"key":"535_CR39","doi-asserted-by":"crossref","first-page":"f6633","DOI":"10.1136\/bmj.f6633","volume":"347","author":"H Khalili","year":"2013","unstructured":"Khalili H, Ananthakrishnan AN, Konijeti GG, et al. Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses\u2019 Health Study cohorts. BMJ. 2013;347:f6633.","journal-title":"BMJ"},{"issue":"144","key":"535_CR40","doi-asserted-by":"crossref","first-page":"S-48","DOI":"10.1016\/S0016-5085(13)60168-7","volume":"5","author":"H Khalili","year":"2013","unstructured":"Khalili H, Ananthakrishnan AN, Higuchi LM, et al. 222 Measures of adiposity and risk of Crohn\u2019s disease and ulcerative colitis. Gastroenterology. 2013;5(144):S-48.","journal-title":"Gastroenterology"},{"issue":"9793","key":"535_CR41","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0140-6736(11)60813-1","volume":"378","author":"BA Swinburn","year":"2011","unstructured":"Swinburn BA, Sacks G, Hall KD, et al. The global obesity pandemic: shaped by global drivers and local environments. The Lancet. 2011;378(9793):804\u201314.","journal-title":"The Lancet"},{"issue":"3","key":"535_CR42","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s10620-010-1541-6","volume":"56","author":"MA Mendall","year":"2011","unstructured":"Mendall MA, Gunasekera AV, John BJ, et al. Is obesity a risk factor for Crohn\u2019s disease? Dig Dis Sci. 2011;56(3):837\u201344.","journal-title":"Dig Dis Sci"},{"key":"535_CR43","doi-asserted-by":"crossref","unstructured":"Harps\u00f8e MC, Basit S, Andersson M et al. Body mass index and risk of autoimmune diseases: a study within the Danish National Birth Cohort.\u00a0Int J Epidemiol. 2014;43:843\u201355","DOI":"10.1093\/ije\/dyu045"},{"issue":"6","key":"535_CR44","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","volume":"55","author":"J Satsangi","year":"2006","unstructured":"Satsangi J, Silverberg MS, Vermeire S, Colombel J. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55(6):749\u201353.","journal-title":"Gut"},{"issue":"10","key":"535_CR45","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/apt.12501","volume":"38","author":"CE Spooren","year":"2013","unstructured":"Spooren CE, Pierik MJ, Zeegers MP, et al. Review article: the association of diet with onset and relapse in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013;38(10):1172\u201387.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"535_CR46","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.crohns.2011.05.010","volume":"5","author":"TS Hansen","year":"2011","unstructured":"Hansen TS, Jess T, Vind I, et al. Environmental factors in inflammatory bowel disease: a case-control study based on a Danish inception cohort. J Crohns Colitis. 2011;5(6):577\u201384.","journal-title":"J Crohns Colitis"},{"issue":"4","key":"535_CR47","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/ajg.2011.44","volume":"106","author":"JK Hou","year":"2011","unstructured":"Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011;106(4):563\u201373.","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"535_CR48","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/gut.31.9.1037","volume":"31","author":"A Sonnenberg","year":"1990","unstructured":"Sonnenberg A. Occupational distribution of inflammatory bowel disease among German employees. Gut. 1990;31(9):1037\u201340.","journal-title":"Gut"},{"issue":"3","key":"535_CR49","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/ije\/25.3.630","volume":"25","author":"H Boggild","year":"1996","unstructured":"Boggild H, Tuchen F, Orhede E. Occupation, employment status and chronic inflammatory bowel disease in Denmark. Int J Epidemiol. 1996;25(3):630\u20137.","journal-title":"Int J Epidemiol"},{"issue":"2","key":"535_CR50","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/ije\/22.2.268","volume":"22","author":"PG Persson","year":"1993","unstructured":"Persson PG, Leijonmarck CE, Bernell O, et al. Risk indicators for inflammatory bowel disease. Int J Epidemiol. 1993;22(2):268\u201372.","journal-title":"Int J Epidemiol"},{"issue":"3","key":"535_CR51","first-page":"247","volume":"30","author":"I Klein","year":"1998","unstructured":"Klein I, Reif S, Farbstein H, et al. Preillness non dietary factors and habits in inflammatory bowel disease. Ital J Gastroenterol Hepatol. 1998;30(3):247\u201351.","journal-title":"Ital J Gastroenterol Hepatol"},{"issue":"11","key":"535_CR52","first-page":"711","volume":"9","author":"AN Dam","year":"2013","unstructured":"Dam AN, Berg AM, Farraye FA, et al. Environmental influences on the onset and clinical course of Crohn\u2019s disease\u2014Part 1: An overview of external risk factors. Gastroenterol Hepatol. 2013;9(11):711.","journal-title":"Gastroenterol Hepatol"},{"issue":"11","key":"535_CR53","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.4065\/81.11.1462","volume":"81","author":"SS Mahid","year":"2006","unstructured":"Mahid SS, Minor KS, Soto RE, et al. Smoking and inflammatory bowel disease: a meta-analysis. May Clin Proc. 2006;81(11):1462\u201371. Elsevier.","journal-title":"May Clin Proc"},{"issue":"3","key":"535_CR54","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2036.2012.05173.x","volume":"36","author":"J Juilerat","year":"2012","unstructured":"Juilerat J, Schneeweiss S, Cook EF, et al. Drugs that inhibit gastric acid secretion may alter the course of inflammatory bowel disease. Aliment Pharmacol Ther. 2012;36(3):239\u201347.","journal-title":"Aliment Pharmacol Ther"},{"key":"535_CR55","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1016\/S1873-9946(14)60247-6","volume":"8","author":"YM Han","year":"2014","unstructured":"Han YM, Koh SJ, Kim JW, et al. P125 The effect of suppressing gastric acid secretion in Crohn\u2019s disease. J Crohns Colitis. 2014;8:S114\u20135.","journal-title":"J Crohns Colitis"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-016-0535-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T06:09:32Z","timestamp":1568441372000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-016-0535-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,7]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["535"],"URL":"https:\/\/doi.org\/10.1186\/s12876-016-0535-z","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,7]]},"article-number":"126"}}